Gene · 9682
Papers1,858
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,858
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| H3 histone methylation landscape in male urogenital cancers: from molecular mechanisms to epigenetic biomarkers and therapeutic targets. | Front Cell Dev Biol | 2023 | 37228649 | PubTator, text mining | PubMed |
| Histone Demethylase Modulation: Epigenetic Strategy to Combat Cancer Progression. | Epigenomes | 2023 | 37218871 | PubTator, text mining | PubMed |
| Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets. | Signal Transduct Target Ther | 2023 | 37217462 | PubTator, text mining | PubMed |
| The function of histone methylation and acetylation regulators in GBM pathophysiology. | Front Oncol | 2023 | 37205197 | PubTator, text mining | PubMed |
| Cantharidin suppresses hepatocellular carcinoma development by regulating EZH2/H3K27me3-dependent cell cycle progression and antitumour immune response. | BMC Complement Med Ther | 2023 | 37202806 | PubTator, text mining | PubMed |
| Comprehensive transcriptomic analyses identify KDM genes-related subtypes with different TME infiltrates in gastric cancer. | BMC Cancer | 2023 | 37202737 | PubTator, text mining | PubMed |
| Prioritization of potential causative genes for schizophrenia in placenta. | Nat Commun | 2023 | 37188697 | PubTator, text mining | PubMed |
| Histone Demethylation Profiles in Nonalcoholic Fatty Liver Disease and Prognostic Values in Hepatocellular Carcinoma: A Bioinformatic Analysis. | Curr Issues Mol Biol | 2023 | 37185761 | PubTator, text mining | PubMed |
| The pattern of histone H3 epigenetic posttranslational modifications is regulated by the VRK1 chromatin kinase. | Epigenetics Chromatin | 2023 | 37179361 | Swiss-Prot, curated | PubMed |
| Cis-regulatory atlas of primary human CD4+ T cells. | BMC Genomics | 2023 | 37170195 | PubTator, text mining | PubMed |
| JMJD2A participates in cytoskeletal remodeling to regulate castration-resistant prostate cancer docetaxel resistance. | BMC Cancer | 2023 | 37165308 | PubTator, text mining | PubMed |
| The KDM5B and KDM1A lysine demethylases cooperate in regulating androgen receptor expression and signalling in prostate cancer. | Front Cell Dev Biol | 2023 | 37152294 | PubTator, text mining | PubMed |
| Machine learning-based construction of a ferroptosis and necroptosis associated lncRNA signature for predicting prognosis and immunotherapy response in hepatocellular cancer. | Front Oncol | 2023 | 37152064 | PubTator, text mining | PubMed |
| H3K4me3-related lncRNAs signature and comprehensive analysis of H3K4me3 regulating tumor immunity in lung adenocarcinoma. | Respir Res | 2023 | 37131252 | PubTator, text mining | PubMed |
| Oncohistones and disrupted development in pediatric-type diffuse high-grade glioma. | Cancer Metastasis Rev | 2023 | 37119408 | PubTator, text mining | PubMed |
| KDM4C silencing inhibits cell migration and enhances radiosensitivity by inducing CXCL2 transcription in hepatocellular carcinoma. | Cell Death Discov | 2023 | 37117173 | PubTator, text mining | PubMed |
| HMGXB4 Targets Sleeping Beauty Transposition to Germinal Stem Cells. | Int J Mol Sci | 2023 | 37108449 | PubTator, text mining | PubMed |
| PRDM1 DNA-binding zinc finger domain is required for normal limb development and is disrupted in split hand/foot malformation. | Dis Model Mech | 2023 | 37083955 | PubTator, text mining | PubMed |
| Unraveling the Post-Translational Modifications and therapeutical approach in NSCLC pathogenesis. | Transl Oncol | 2023 | 37062237 | PubTator, text mining | PubMed |
| A multi-omics integrative analysis based on CRISPR screens re-defines the pluripotency regulatory network in ESCs. | Commun Biol | 2023 | 37059858 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9682/papers?page=11